Cocaine and ephedrine-induced priapism: Case reports and investigation of potential adrenergic mechanisms

Urology

Volumn 62, Issue 1, 2003, Pages 187-192

  Munarriz, Ricardo ^a   Hwang, Jonathan ^a   Goldstein, Irwin ^a   Traish, Abdulmaged M ^a   Kim, Noel N ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; EPHEDRINE; PHENYLEPHRINE; SODIUM CHLORIDE;

ADRENERGIC SYSTEM; ADULT; ANIMAL TISSUE; ARTICLE; CASE REPORT; CLINICAL FEATURE; COCAINE DEPENDENCE; CONCENTRATION RESPONSE; CORPUS CAVERNOSUM; DIET SUPPLEMENTATION; DISEASE COURSE; ELECTROSTIMULATION; HUMAN; ISOLATED ORGAN; LAVAGE; MALE; NONHUMAN; PRIAPISM; PRIORITY JOURNAL; RABBIT; SHUNTING; SMOOTH MUSCLE CONTRACTION; WEIGHT REDUCTION;

EID: 0038353462     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00245-0     Document Type: Article

References (31)

1. Fiorelli R.L., Manfrey S.J., Belkoff L.H., et al. Priapism associated with intranasal cocaine abuse. J Urol. 143:1990;584-585.
2. Mahler J.C., Perry S., Sutton B. Intraurethral cocaine administration. JAMA. 259:1988;3126.
3. Mireku-Boateng A.O., Tasie B. Priapism associated with intracavernosal injection of cocaine. Urol Int. 67:2001;109-110.
4. Rodriguez-Blaquez H.M., Cardona P.E., Rivera-Herrera J.L. Priapism associated with the use of topical cocaine. J Urol. 143:1990;358.
5. Altman A.L., Seftel A.D., Brown S.L., et al. Cocaine associated priapism. J Urol. 161:1999;1817-1818.
6. Braun B.L., Murray D., Hannan P., et al. Cocaine use and characteristics of young adult users from 1987 to 1992 the CARDIA Study. Coronary artery risk development in young adults . Am J Public Health. 86:1996;1736-1741.
7. Abelson H.I., Miller J.D. A decade of trends in cocaine use in the household population. NIDA Res Monogr. 61:1985;35-49.
8. Goldbeck-Wood S., Dorozynski A., Lie L.G., et al. Complementary medicine is booming worldwide. BMJ. 313:1996;131-133.
9. Rasmussen N.K., Morgall J.M. The use of alternative treatments in the Danish adult population. Complementary Med Res. 4:1990;16-22.
10. Vaskilampi T., Meriläinen P., Sinkkonen S., et al. The use of alternative treatments in the Finnish adult population. Lewith G.T., Aldridge D. Clinical Research Methodology for Complementary Therapies. 1993;204-229 Hodder & Stoughton, London.
11. MacLennan A.H., Wilson D.H., Taylor A.W. Prevalence and cost of alternative medicine in Australia. Lancet. 347:1996;569-573.
12. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997 results of a follow-up national survey . JAMA. 280:1998;1569-1575.
13. Saenz de Tejada I., Blanco R., Goldstein I., et al. Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue. Am J Physiol. 254:1988;H459-H467.
14. Draper A.J., Kendall H.E., Redfern P.H. The chronic effects of beta-adrenoreceptor antagonists on the efflux of tritiated noradrenaline from sympathetic nerves of the pithed rat. J Auton Pharmacol. 6:1986;259-268.
15. Dahlof C., Ljung B., Ablad B. Increased noradrenaline release in rat portal vein during sympathetic nerve stimulation due to activation of presynaptic beta-adrenoceptors by noradrenaline and adrenaline. Eur J Pharmacol. 50:1978;75-78.
16. 2-adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves. Acta Physiol Scand. 97:1976;88-93.
17. Louis J.C., Magal E., Varon S. Receptor-mediated toxicity of norepinephrine on cultured catecholaminergic neurons of the rat brain stem. J Pharmacol Exp Ther. 262:1992;1274-1283.
18. Michel P.P., Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res. 26:1990;428-435.
19. Rosenberg P.A. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci. 8:1988;2887-2894.
20. Saenz de Tejada I., Kim N., Lagan I., et al. Regulation of adrenergic activity in penile corpus cavernosum. J Urol. 142:1989;1117-1121.
21. 3H]-5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol. 81:1982;97-106.
22. Mattiasson A., Andersson K.E., Sjögren C. Adrenoceptors and cholinoceptors controlling noradrenaline release from adrenergic nerves in the urethra of rabbit and man. J Urol. 131:1984;1190-1195.
23. 3H]noradrenaline from rat spinal cord. Brain Res. 42:1997;129-132.
24. Steers W.D., de Groat W.C. Effects of m-chlorophenylpiperazine on penile and bladder function in rats. Am J Physiol. 257:1989;R1441-R1449.
25. Cohen M.L., Schenck K.W., Hemrick-Luecke S.H. 5-Hydroxytryptamine 1A receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein. J Pharmacol Exp Ther. 290:1999;1195-1201.
26. Jones RT: The pharmacology of cocaine smoking in humans, in Chiang CN, and Hawks RL (Eds): Research Findings on Smoking of Abused Substances. NIDA Research Monograph, Department of Health and Human Services, Publication No. ADM90-1690, 1990, vol 99, pp 30-41.
27. San Diego Reference Laboratory web site (accessed February 2003). www.sdrl.com/druglist/cocaine.html.
28. White L.M., Gardner S.F., Gurley B.J., et al. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol. 37:1997;116-122.
29. Gurley B.J., Gardner S.F., Hubbard M.A. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. 57:2000;963-969.
30. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signaling. Clin Med. 2:2002;45-53.
31. Todorov L.D., Bjur R.A., Westfall D.P. Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves. J Pharmacol Exp Ther. 268:1994;985-989.